2m 2m 2m 2m 2m 2m 2m
Harmony Bioscien (HRMY)
NASDAQ
$34.15+$0.72 (+2.15%)
Price as of Jun 23, 2026 7:43 PM EDT- $1.9BMarket Cap
- 4.70%1-Year Change
- BiotechnologyIndustry
Harmony Bioscien (HRMY)
$34.15+$0.72 (+2.15%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 868.5M +21.51% | 714.7M +22.80% | 582.0M +32.93% | 437.9M +43.35% | |
Cost of Revenue | 198.3M +26.48% | 156.8M +29.35% | 121.2M +45.23% | 83.5M +50.37% | |
Gross Profit | 670.1M +20.11% | 557.9M +21.08% | 460.8M +30.03% | 354.4M +41.79% | |
Sales and Marketing Expense | 119.5M +7.75% | 110.9M +13.87% | 97.4M +22.85% | 79.3M +16.39% | |
Research and Development Expense | -189.6M +30.01% | -145.8M +91.72% | -76.1M +7.30% | -70.9M +133.43% | |
Depreciation and Amortization Expense | 23.8M 0.00% | 23.8M 0.00% | 23.8M +3.83% | 23.0M +24.65% | |
Total Operating Expenses | 461.6M +25.76% | 367.1M +36.59% | 268.8M +14.76% | 234.2M +44.21% | |
Operating Profit | 208.5M +9.25% | 190.8M -0.63% | 192.0M +59.78% | 120.2M +37.31% | |
Interest Income | 21.9M +18.24% | 18.5M +25.88% | 14.7M N/A | N/A N/A | |
Interest Expense | -14.6M -16.27% | -17.5M -26.35% | -23.8M +51.62% | -15.7M -34.63% | |
Interest Income and Expense and Net | 7.3M +595.51% | 1.0M +111.59% | -9.0M -42.39% | -15.7M -34.63% | |
Total Nonoperating Income and Expense | -680,000 +900.00% | -68,000 -142.77% | 159,000 -5.92% | 169,000 +956.25% | |
Income before Taxes | 215.1M +12.13% | 191.8M +10.62% | 173.4M +65.63% | 104.7M +179.70% | |
Income Taxes | 56.4M +21.74% | 46.3M +3.97% | 44.5M +158.01% | -76.8M -2,812.19% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 158.7M +9.07% | 145.5M +12.91% | 128.9M -28.99% | 181.5M +424.52% | |
Net Income from Continuing Operations Applicable to Common | 215.1M +12.13% | 191.8M +10.62% | 173.4M -4.45% | 181.5M +424.52% | |
Basic EPS and Net Income | 2.76 +7.81% | 2.56 +17.97% | 2.17 -29.32% | 3.07 +411.67% | |
Diluted EPS and Net Income | 2.71 +7.97% | 2.51 +17.84% | 2.13 -28.28% | 2.97 +412.07% | |
Basic Weighted Average Shares | 57.5M +1.07% | 56.9M -4.35% | 59.5M +0.50% | 59.2M +2.85% | |
Diluted Weighted Average Shares | 58.5M +1.17% | 57.9M -4.15% | 60.4M -1.19% | 61.1M +3.20% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 752.5M +66.11% | 453.0M +45.35% | 311.7M +27.84% | 243.8M +4.04% | |
Short-Term Investments | 22.8M +61.00% | 14.2M -66.06% | 41.8M -47.31% | 79.3M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 775.3M +65.96% | 467.2M +32.18% | 353.5M +9.39% | 323.1M +37.90% | |
Total Current Assets | 907.0M +56.58% | 579.3M +28.42% | 451.1M +12.69% | 400.3M +40.73% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | 1.3M +238.81% | 371,000 -35.25% | 573,000 -30.12% | |
Total Long-Term Assets | 364.6M -13.18% | 419.9M +16.53% | 360.4M +31.72% | 273.6M +83.61% | |
Total Assets | 1.3B +27.26% | 999.2M +23.14% | 811.4M +20.42% | 673.9M +55.47% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 20.0M +23.08% | 16.3M +8.33% | 15.0M +650.00% | 2.0M 0.00% | |
Total Current Liabilities | 252.1M +44.01% | 175.1M +6.90% | 163.8M +107.62% | 78.9M +46.69% | |
Total Long-Term Debt | 143.7M -11.87% | 163.0M -8.71% | 178.6M -5.84% | 189.6M -0.18% | |
Total Long-Term Liabilities | 149.3M -9.51% | 165.0M -8.70% | 180.7M -5.97% | 192.1M -0.52% | |
Total Liabilities | 401.4M +18.05% | 340.0M -1.28% | 344.5M +27.09% | 271.0M +9.76% | |
Retained Earnings | 160.9M +7,160.97% | 2.2M +101.55% | -143.3M -47.35% | -272.1M -40.01% | |
Total Stockholders Equity | 870.2M +32.02% | 659.2M +41.15% | 467.0M +15.93% | 402.8M +115.99% | |
Total Shares Outstanding | 57.7M +1.02% | 57.1M +0.66% | 56.8M -4.77% | 59.6M +1.34% | |
Cash Flow | |||||
Cash from Operating Activities | 348.2M +58.40% | 219.8M +0.20% | 219.4M +51.86% | 144.5M +46.58% | |
Capital Expenditures | 310,000 -73.11% | 1.2M +269.55% | 312,000 +81.40% | 172,000 -42.28% | |
Cash from Investing Activities | -39.6M -41.25% | -67.5M +45.32% | -46.4M -67.26% | -141.8M +41.41% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -9.0M -17.71% | -11.0M -89.58% | -105.6M -1,642.93% | 6.8M -7.79% | |
Financials Ratio | |||||
Gross Margin | 77.16% -1.15% | 78.06% -1.40% | 79.17% -2.18% | 80.93% -1.09% | |
Operating Margin | 24.00% -10.09% | 26.70% -19.08% | 32.99% +20.20% | 27.45% -4.21% | |
Return on Assets | 13.98% -13.03% | 16.07% -7.37% | 17.35% -47.06% | 32.78% +307.61% | |
Return on Equity | 20.75% -19.69% | 25.84% -12.79% | 29.63% -51.89% | 61.58% +152.48% | |
Revenue Growth | 21.51% -5.68% | 22.80% -30.75% | 32.93% -24.05% | 43.35% -52.47% | |
Current Ratio | 3.60 +8.73% | 3.31 +20.13% | 2.75 -45.72% | 5.07 -4.07% | |
Cash Ratio | 2.98 +15.35% | 2.59 +35.97% | 1.90 -38.43% | 3.09 -29.07% | |
Debt-to-Equity Ratio | 0.19 -30.85% | 0.27 -34.38% | 0.41 -12.87% | 0.48 -53.79% | |
Debt-to-Assets Ratio | 0.13 -28.26% | 0.18 -24.78% | 0.24 -16.14% | 0.28 -35.79% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow